Sharing Progress in Cancer Care (SPCC) shared a post on LinkedIn:
“Now available on demand: the third webinar of the EU-funded Definitive Trial project.
In this session, experts Tal Sella, Paola Zagami, and Alexandru Eniu explore:
- The biological foundations of anti-HER2 therapies
- Practical approaches to managing anti-HER2 toxicities
CME accredited and free of charge (registration required).
Access the webinar here.
Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).”
More posts featuring SPPC.